Bridgene Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.bridgenebio.com
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- MesotheliomaEpithelioid Hemangioendothelioma(EHE)Solid Tumor
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- BridGene Biosciences Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT06452160
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath